New Indication: Antiepileptic cleared for Lennox-Gastaut syndrome; glaucoma warning added
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Intercept Withdraws Ocaliva from Market After FDA Raises Safety Concerns
Read More
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
Listen
ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain
Updated: FDA Approves Leqembi Autoinjector for Maintenance Dosing in Alzheimer’s
Teva Launches First Generic GLP-1 Drug for Obesity
Novo Nordisk Teams with Form Health, 9amHealth for Obesity Care